S.D. Codified Laws § 34-20B-12

Current through the 2024 Legislative Session

Section 34-20B-12 - Specific substances included in Schedule I

Any of the following substances, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers, is included in Schedule I, unless specifically excepted, whenever the existence of such isomers, esters, ethers, and salts is possible within the specific chemical designation:

(1) Acetylmethadol;

(2) Allylprodine;

(3) Alphacetylmethadol, except levo-alphacetylmethadol, also known as levo-alpha-acetylmethadol, levomethadyl acetate or LAAM;

(4) Alphameprodine;

(5) Alphamethadol;

(6) Benzethidine;

(7) Betacetylmethadol;

(8) Betameprodine;

(9) Betamethadol;

(10) Betaprodine;

(11) Clonitazene;

(12) Dextromoramide;

(13) Diampromide;

(14) Diethyliambutene;

(15) Dimenoxadol;

(16) Dimepheptanol;

(17) Dimethyliambutene;

(18) Dioxaphetyl butyrate;

(19) Dipipanone;

(20) Ethylmethylthiambutene;

(21) Etonitazene;

(22) Etoxeridine;

(23) Fenethylline;

(24) Furethidine;

(25) Hydroxypethidine;

(26) Ketobemidone;

(27) Levomoramide;

(28) Levophenacylmorphan;

(29) Mecloqualone;

(30) Morpheridine;

(31) Noracymethadol;

(32) Norlevorphanol;

(33) Normethadone;

(34) Norpipanone;

(35) Phenadoxone;

(36) Phenampromide;

(37) Phenomorphan;

(38) Phenoperidine;

(39) Piritramide;

(40) Proheptazine;

(41) Properidine;

(42) Racemoramide;

(43) Trimeperidine;

(44) Methaqualone;

(45) N-benzylpiperazine;

(46) 4-chloro-N-[1-[2-(4-nitrophenyl)ethyl]-2-piperidinylidene]-benzenesulfonamide, W-18;

(47) N,N-diethyl-2-(2-(4 isopropoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine, also known as isotonitazene;

(48) 2-(2-(4-butoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine (butonitazene);

(49) 2-(2-(4-ethoxybenzyl)-1H-benzimidazol-1-yl)-N,N-diethylethan-1-amine (etodesnitazene, etazene);

(50) N,N-diethyl-2-(2-(4-fluorobenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine) (flunitazene);

(51) N,N-diethyl-2-(2-(4-methoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine (metodesnitazene);

(52) N,N-diethyl-2-(2-(4-methoxybenzyl)-5-nitro-1H-benzimidazol-1-yl)ethan-1-amine (metonitazene);

(53) 2-(4-ethoxybenzyl)-5-nitro-1-(2-(pyrrolidin-1-yl)ethyl)-1H-benzimidazole (N-pyrrolidino etonitazene, etonitazepyne);

(54) N,N-diethyl-2-(5-nitro-2-(4-propoxybenzyl)-1H-benzimidazol-1-yl)ethan-1-amine (protonitazene);

(55) 7-[(10,11-dihydro-5 H -dibenzo[a,d]cyclohepten-5-yl)amino]heptanoic acid) (amineptine);

(56) N -phenyl- N'? -(3-(1-phenylpropan-2-yl)-1,2,3-oxadiazol-3-ium-5-yl)carbamimidate) (mesocarb); and

(57) N -methyl-1-(thiophen-2-yl)propan-2-amine (methiopropamine).

SDCL 34-20B-12

SL 1970, ch 229, § 8 (a) (1); SDCL Supp, § 39-17-55; SL 1977, ch 315, § 1; SL 1985, ch 278, § 50; SL 1994, ch 278, § 1; SL 2003, ch 183, §1; SL 2018, ch 203, §1, eff. Feb. 8, 2018; SL 2021, ch 144, §1, eff. Feb. 17, 2021; SL 2022, ch 109, §1, eff. Feb. 9, 2022; SL 2024, ch 130, §1, eff. Feb. 14, 2024.

Amended by S.L. 2024, ch. 130,s. 1, eff. 2/14/2024.

Amended by S.L. 2022, ch. 109,s. 1, eff. 2/9/2022.

Amended by S.L. 2021, ch. 144,s. 1, eff. 2/17/2021.

Amended by S.L. 2018, ch. 203,s. 1, eff. 2/8/2018.